Dementia and Alzheimer's disease: What we know now

Generations

Volumn 35, Issue 2, 2011, Pages 37-45

  Wierenga, Christina ^a   Bondi, Mark ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80155132365     PISSN: 07387806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Albert, M. S., et al. 2001. "Preclinical Prediction of AD Using Neuropsychological Tests." Journal of the International Neuropsychological Society 7(5): 631-9.
2. Alzheimer's Association. 2010a. "2010 Alzheimer's Disease Facts and Figures." Alzheimer's & Dementia 6(2): 158-94.
3. Alzheimer's Association. 2010b. "New Diagnostic Criteria for Alzheimer's Disease." www.alz.org/research/diagnostic-criteria. Retrieved July 13, 2011.
4. American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, D.C.
5. Barak, Y., and Aizenberg, D. 2010. "Is Dementia Preventable? Focus on Alzheimer's Disease." Expert Reviews Neurotherapeutics 10(11): 1689-98.
6. Bondi, M. W., et al. 2003. "Neuropsychological Deficits Associated with Alzheimer's Disease in the Very-Old: Discrepancies in Raw vs. Standardized Scores." Journal of the International Neuropsychological Society 9(5): 783-95.
7. Bondi, M. W., et al. 2008. "Neuropsychological Contributions to the Early Identification of Alzheimer's Disease." Neuropsychology Review 18(1): 73-90.
8. Braak, H., and Braak, E. 1991. "Neuropathological Stageing of Alzheimer-Related Changes." Acta Neuropathologica 82(4): 239-59.
9. Craik, F. I., Bialystok, E., and Freedman, M. 2011. "Delaying the Onset of Alzheimer Disease: Bilingualism as a Form of Cognitive Reserve." Neurology 75(19): 1726-9.
10. Daviglus, M. L., et al. 2010. "NIH Consensus Development Conference Statement on Venting Alzheimer's Disease and Cognitive Decline." NIH Consensus and State-of-the-Science Statements 27(4): 1-30.
11. Dubois, B., et al. 2007. "Research Criteria for the Diagnosis of Alzheimer's Disease: Revising the NINCDS-ADRDA Criteria." Lancet Neurology 6(8): 734-46.
12. Dubois, B., et al. 2010. "Revising the Definition of Alzheimer's Disease: A New Lexicon." Lancet Neurology 9(11): 1118-27.
13. Jack, C. R., et al. 2010. "Hypothetical Model of Dynamic Biomarkers of the Alzheimer's Pathological Cascade." Lancet Neurology 9(1): 119-28.
14. Jacobson, M. W., et al. 2002. "Do Neuropsychological Tests Detect Preclinical Alzheimer's Disease: Individual-Test Versus Cognitive-Discrepancy Score Analyses." Neuropsychology 16(2): 132-9.
15. Jak, A. J., et al. 2009. "Quantification of Five Neuropsychological approaches to Defining MCI." American Journal of Geriatric Psychiatry 17(5): 368-75.
16. McKhann, G., et al. 1984. "Clinical Diagnosis of Alzheimer's Disease: Report of the NINCDS-ADRDA Work Group Under the Auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease." Neurology 34(7): 939-44.
17. Naj, A. C., et al. 2011. "Common Variants at MS4A4/MS4A6E, CD2AP, CD33, and EPHA1 Are Associated With Late-Onset Alzheimer's Disease." Nature Genetics 43(5):436-441.
18. Patterson, C., et al. 2008. "Diagnosis and Treatment of Dementia: 1. Risk Assessment and Primary Prevention of Alzheimer's Disease." Canadian Medical Association Journal 178(5): 548-56.
19. Petersen, R. C., and Morris, J. C. 2005. "Mild Cognitive Impairment as a Clinical Entity and Treatment Target." Archives of Neurology 62(7): 1160-3; discussion 1167.
20. Prvulovic, D., and Hampel, H. 2011. "Amyloid â (Aâ) and Phospho-tau (p-tau) as Diagnostic Biomarkers in Alzheimer's Disease." Clinical Chemistry and Laboratory Medicine 49(3): 367-74.
21. Salmon, D. P., and Bondi, M. W. 2009. "Neuropsychological Assessment of Dementia." Annual Review of Psychology 60: 257-82.
22. Small, B. J., et al. 2003. "Cognitive Deficits in Preclinical Alzheimer's Disease." Acta Neurological Scandinavia Supplement 179: 29-33.
23. Sperling, R. A., et al. 2011. "Toward Defining the Preclinical Stages of Alzheimer's Disease." Alzheimer's & Dementia 7(3): 280-92.
24. Twamley, E. W., Ropacki, S. A., and Bondi, M. W. 2006. "Neuropsychological and Neuroimaging Changes in Preclinical Alzheimer's Disease." Journal of the International Neuropsychological Society 12(5): 707-35.
25. Wierenga, C. E., and Bondi, M. W. 2007. "Use of Functional Magnetic Resonance Imaging in the Early Identification of Alzheimer's Disease." Neuropsychology Review 17: 127-43.
26. Winblad, B., et al. 2004. "Mild Cognitive Impairment-Beyond Controversies, Towards a Consensus: Report of the International Working Group on Mild Cognitive Impairment." Journal of Internal Medicine 256(3): 240-6